Concurrent Chemoradiotherapy for Salvage in Relapsed Squamous Cell Head and Neck Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concurrent Chemoradiotherapy for Salvage in Relapsed Squamous Cell Head and Neck Cancer

Published:1997-01 Issue:5 Volume:15 Page:422-428
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Tan Eng-Huat,Adelstein David J.,Saxton Jerrold P.,Wood Benjamin G.,Eliachar Isaac,Van Kirk Marjorie A.,Lavertu Pierre

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07357909709047581

Reference18 articles.

1. Chemotherapy for Recurrent and Metastatic Head and Neck Cancer

2. REIRRADIATION OF RECURRENT HEAD AND NECK CANCERS

3. Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy

4. Interstitial re-irradiation for recurrent and/or persistent head and neck cancers

5. Intraoperative radiation therapy for recurrent head and neck cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma;Chinese Journal of Cancer;2016-02-15

2. Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy;Strahlentherapie und Onkologie;2015-01-10

3. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma;Brachytherapy;2014-03

4. Salvage Re-Irradiation for Recurrent Head and Neck Cancer;International Journal of Radiation Oncology*Biology*Physics;2007-07

5. Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer;Journal of Bioenergetics and Biomembranes;2007-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3